Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-09-14
DOI
10.3389/fphar.2016.00309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
- (2016) Ashley C. Bradford et al. HEALTH AFFAIRS
- Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
- (2016) C Mokrysz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Keep off the grass? Cannabis, cognition and addiction
- (2016) H. Valerie Curran et al. NATURE REVIEWS NEUROSCIENCE
- Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis
- (2016) Christian Lanz et al. PLoS One
- Beyond Cannabis: Plants and the Endocannabinoid System
- (2016) Ethan B. Russo TRENDS IN PHARMACOLOGICAL SCIENCES
- Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
- (2016) J K L Gunn et al. BMJ Open
- US states that allow medical marijuana see drop in prescriptions for other drugs, study finds
- (2016) Owen Dyer BMJ-British Medical Journal
- US states that allow medical marijuana see drop in prescriptions for other drugs, study finds
- (2016) Owen Dyer BMJ-British Medical Journal
- Hippocampal harms, protection and recovery following regular cannabis use
- (2016) M Yücel et al. Translational Psychiatry
- Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis
- (2016) Arno Hazekamp Frontiers in Pharmacology
- Cannabinoids in the management of difficult to treat pain
- (2016) Ethan Russo Therapeutics and Clinical Risk Management
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Associations of adolescent cannabis use with academic performance and mental health: A longitudinal study of upper middle class youth
- (2015) Madeline H. Meier et al. DRUG AND ALCOHOL DEPENDENCE
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Method for the Analysis of Cannabinoids and Terpenes in Cannabis
- (2015) Matthew W. Giese et al. JOURNAL OF AOAC INTERNATIONAL
- Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing
- (2015) Jeffrey C. Raber et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Hidden Formaldehyde in E-Cigarette Aerosols
- (2015) R. Paul Jensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increasing placebo responses over time in U.S. clinical trials of neuropathic pain
- (2015) Alexander H. Tuttle et al. PAIN
- A new method of cannabis ingestion: The dangers of dabs?
- (2014) Mallory Loflin et al. ADDICTIVE BEHAVIORS
- Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience
- (2014) Jürgen Koehler EUROPEAN NEUROLOGY
- THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies
- (2014) Tiina Rekand EUROPEAN NEUROLOGY
- Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
- (2014) Marcus A. Bachhuber et al. JAMA Internal Medicine
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- (2013) Colin Stott et al. SpringerPlus
- Evaluation of the safety and tolerability profile of Sativex®: is it reassuring enough?
- (2012) Derick Wade Expert Review of Neurotherapeutics
- Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
- (2012) Michael G. Serpell et al. JOURNAL OF NEUROLOGY
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach
- (2012) Stephen Wright et al. Trials
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine
- (2012) William G. Notcutt Primary Health Care Research and Development
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas—possible role of Cannabis inhalation
- (2011) Mansoor Foroughi et al. CHILDS NERVOUS SYSTEM
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
- (2011) Philip Robson Expert Opinion On Drug Safety
- A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
- (2011) Kerri Alexandra Schoedel et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?
- (2010) John Macleod et al. ADDICTION
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes
- (2010) Justin Thomas Fischedick et al. PHYTOCHEMISTRY
- If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
- (2009) Matt Hickman et al. ADDICTION
- Evaluation of the DNA Damaging Potential of Cannabis Cigarette Smoke by the Determination of Acetaldehyde Derived N2-Ethyl-2′-deoxyguanosine Adducts
- (2009) Rajinder Singh et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Cannabis smoke condensate III: The cannabinoid content of vaporisedCannabis sativa
- (2009) B. Pomahacova et al. INHALATION TOXICOLOGY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users
- (2008) Roger N. Bloor et al. ADDICTION
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
- (2008) Kirsten R Müller-Vahl et al. Expert Review of Neurotherapeutics
- Cannabis Smoke Condensate I: The Effect of Different Preparation Methods on Tetrahydrocannabinol Levels
- (2008) F. Van der Kooy et al. INHALATION TOXICOLOGY
- Effect of intrapulmonary tetrahydrocannabinol administration in humans
- (2008) L. Zuurman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy☆
- (2008) Cory Toth et al. PAIN
- Beta-caryophyllene is a dietary cannabinoid
- (2008) Jürg Gertsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking Conditions
- (2007) David Moir et al. CHEMICAL RESEARCH IN TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started